AAAAAA
Results:
1-7
|
Results: 7
Authors:
PARIDAENS R
ROY JA
NOOIJ M
KLIJN J
HOUSTON SJ
BEEX LVAM
VINHOLES J
TOMIAK E
VANVRECKEM A
LANGENAEKEN C
VANGLABBEKE M
PICCART MJ
Citation: R. Paridaens et al., VOROZOLE (RIVIZOR(TM)) - AN ACTIVE AND WELL TOLERATED NEW AROMATASE INHIBITOR FOR THE TREATMENT OF ADVANCED BREAST-CANCER PATIENTS WITH PRIOR TAMOXIFEN EXPOSURE, Anti-cancer drugs, 9(1), 1998, pp. 29-35
Authors:
AWADA A
VANVRECKEM A
PARIDAENS R
BRUNING PF
KLIJN J
TOMIAK E
VINHOLES J
ROY JA
KUSENDA Z
BOES GH
VANGLABBEKE M
PICCART MJ
Citation: A. Awada et al., EORTC-IDBBC (INVESTIGATIONAL DRUG BRANCH FOR BREAST-CANCER) - 5 YEARSOF EUROPEAN COLLABORATION IN NEW DRUG DEVELOPMENT FOR BREAST-CANCER, European journal of cancer, 33(8), 1997, pp. 1173-1176
Authors:
VINHOLES J
GUO CY
PUROHIT OP
EASTELL R
COLEMAN RE
Citation: J. Vinholes et al., EVALUATION OF NEW BONE-RESORPTION MARKERS IN A RANDOMIZED COMPARISON OF PAMIDRONATE OR CLODRONATE FOR HYPERCALCEMIA OF MALIGNANCY, Journal of clinical oncology, 15(1), 1997, pp. 131-138
Authors:
VINHOLES J
COLEMAN R
EASTELL R
Citation: J. Vinholes et al., EFFECTS OF BONE METASTASES ON BONE METABOLISM - IMPLICATIONS FOR DIAGNOSIS, IMAGING AND ASSESSMENT OF RESPONSE TO CANCER-TREATMENT, Cancer treatment reviews, 22(4), 1996, pp. 289-331
Authors:
VINHOLES J
GUO CY
PUROHIT OP
EASTELL R
COLEMAN RE
Citation: J. Vinholes et al., METABOLIC EFFECTS OF PAMIDRONATE IN PATIENTS WITH METASTATIC BONE-DISEASE, British Journal of Cancer, 73(9), 1996, pp. 1089-1095
Authors:
VINHOLES J
PUROHIT OP
GUO CY
EASTELL R
VINHOLES AP
COLEMAN R
Citation: J. Vinholes et al., RANDOMIZED DOUBLE-BLIND COMPARISON OF PAMIDRONATE OR CLODRONATE FOR HYPERCALCEMIA OF MALIGNANCY - EFFECTS ON BONE METABOLISM MARKERS, European journal of cancer, 31A, 1995, pp. 1211-1211
Authors:
VINHOLES J
COLEMAN R
Citation: J. Vinholes et R. Coleman, THE MANAGEMENT OF BONE METASTASES, Annals of oncology, 6(7), 1995, pp. 713-720
Risultati:
1-7
|